Web17 jun. 2024 · Investor Enquiries Mark Lee, Senior Vice President +852 2121 8200: Annie Cheng, Vice President +1 (973) 567 3786 Media Enquiries Americas – Brad Miles, Solebury Trout +1 (917) 570 7340 (Mobile) Web2 dagen geleden · HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today announces that new and updated ...
HUTCHMED Launches Hong Kong Initial Public Offering - Yahoo …
WebHUTCHMED International Corporation Jan 2024 - Present3 years 4 months Global Regulatory Team Lead for all regions outside of China responsible for development and execution of strategic global... Web12 mrt. 2024 · Sessions are scheduled in Singapore Time (SGT) Displaying One Session Hall 404 Proffered paper session Proffered Paper and Mini Oral session: Gastrointestinal tumours Date Sat, 03.12.2024 Time 14:30 - 15:30 Location Hall 404 Chairs Jeanne Tie (Melbourne, VIC, Australia) Eric Van Cutsem (Leuven, Belgium) Proffered paper session thomas wooden railway 2016
HUTCHMED Launches Hong Kong Initial Public Offering
Web24 jan. 2024 · 67 Background: The global phase 3 FRESCO-2 study, (NCT04322539) demonstrated that fruquintinib (F) vs placebo (P) significantly improved OS (HR=0.66 [95% CI: 0.55-0.80]; p<0.001) and PFS (HR=0.32 [95% CI: 0.27-0.39]; p<0.001) in heavily pre-treated patients (pts) with refractory metastatic colorectal cancer (mCRC). F safety … Web12 apr. 2024 · Hong Kong, Shanghai & Florham Park, NJ — Wednesday, April 12, 2024: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today … Web12 apr. 2024 · HUTCHMED (China) Limited gab bekannt, dass neue und aktualisierte klinische und nicht-klinische Daten zu fünf Arzneimittelkandidaten von HUTCHMED auf der Jahrestagung 2024 der American Association for Cancer Research (AACR 2024) vorgestellt werden, die vom 14. bis 19. April 2024 in Orlando, Florida, stattfinden wird. uk pies and fries